Home › Funds › Diesslin Group, Inc. › JNJ

Diesslin Group, Inc. position in JNJ

JOHNSON & JOHNSON · Health Care

Diesslin Group, Inc. reported holding 4,928 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$1.3M, representing 0.51% of its reported portfolio and ranking #16 among its reported holdings. Diesslin Group, Inc. has disclosed JNJ holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)4.93K sh
Reported value held$1.30M
Portfolio Weight0.51%
First reportedQ4 2025
Last changeAdd
Updated2026-10-14

Last updated: 2026-10-14 · Source: SEC EDGAR Form 13F-HR

How Diesslin Group, Inc.'s JNJ position evolved

Diesslin Group, Inc. first disclosed a stake in JNJ in Q4 2025 at 5,450 shares (US$1.1M). The position peaked in Q3 2026 at 4,928 shares, worth US$1.3M. Across 4 filings, Diesslin Group, Inc. increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 4,928 shares valued at US$1.3M — an increase of 700 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q4 2025 5.45K $1.13M New
Q1 2026 4.67K $1.14M Reduce
Q2 2026 4.23K $1.07M Reduce
Q3 2026 4.93K $1.30M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 33 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$39.93B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has Diesslin Group, Inc. held JNJ?

Diesslin Group, Inc. has disclosed JNJ holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Diesslin Group, Inc.'s current position in JNJ?

As of Q3 2026, Diesslin Group, Inc. holds 4.93K shares of JNJ (JOHNSON & JOHNSON), valued at $1.30M, representing 0.51% of its reported portfolio and ranking #16.

Has Diesslin Group, Inc. been buying or selling JNJ?

In the latest 13F filing (Q3 2026), Diesslin Group, Inc. increased its position in JNJ. The position peaked in Q3 2026 at 4.93K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.